Sophiris Bio (SPHS) PT Raised to $8 at Maxim Group
Tweet Send to a Friend
Maxim Group raised its price target on Sophiris Bio (NASDAQ: SPHS) to $8.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
